Phase
Condition
Opioid Use Disorder
Treatment
fNIRS
Neurocognitive battery
Clinical Study ID
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
men and women with moderate to severe opioid use disorder by Diagnostic andStatistical Manual, version 5, (DSM-V) criteria on a stable (at least one weekwithout change) dose of oral buprenorphine-naloxone or methadone. (for OUD group)
Eligible participants will be between 18-60 years of age;
able to read at an eighth-grade level;
able to speak English.
Exclusion
Exclusion Criteria:
unable to understand or complete the tasks.
Certain mental health conditions, including (but not limited to) bipolar I withcurrent manic episode, schizophrenia, and schizoaffective disorder, determined bythe Principal Investigator (PI) to interfere with study participation.
moderate or severe substance-use disorder (for Healthy Controls)
Study Design
Connect with a study center
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.